| 3TTJ: reference: Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury., Krenitsky VP, Delgado M, Nadolny L, Sahasrabudhe K, Ayala L, Clareen SS, Hilgraf R, Albers R, Kois A, Hughes K, Wright J, Nowakowski J, Sudbeck E, Ghosh S, Bahmanyar S, Chamberlain P, Muir J, Cathers BE, Giegel D, Xu L, Celeridad M, Moghaddam M, Khatsenko O, Omholt P, Katz J, Pai S, Fan R, Tang Y, Shirley MA, Benish B, Blease K, Raymon H, Bhagwat S, Henderson I, Cole AG, Bennett B, Satoh Y, Bioorg Med Chem Lett. 2011 Dec 11. PMID: 22226655 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).